CRVS - Corvus Pharmaceuticals, Inc.
IEX Last Trade
5.3
0.040 0.755%
Share volume: 48,008
Last Updated: Fri 27 Dec 2024 08:30:16 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$5.26
0.04
0.76%
Summary score
21%
Profitability
25%
Dept financing
4%
Liquidity
48%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-12.91%
Return on assets
-11.76%
Return on sales
0%
Return on invested capital
276.3%
Total debt ratio
10.41%
Debt ratio change over timeo
-0.96%
Current Ratio
12.93%
Quick Ratio
0%
Cash Position Ratio
3.26%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-17.91%
Return on assets
-15.22%
Return on sales
0%
Return on invested capital
178.09%
Total debt ratio
16.86%
Debt ratio change over timeo
-0.91%
Current Ratio
7.05%
Quick Ratio
0%
Cash Position Ratio
1.31%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-20.87%
Return on assets
-16.78%
Return on sales
0%
Return on invested capital
133.69%
Total debt ratio
20.78%
Debt ratio change over time
-0.88%
Current Ratio
5.24%
Quick Ratio
0%
Cash Position Ratio
1.79%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.22%
Return on assets
-104.7%
Return on sales
0%
Return on invested capital
-11.74%
Total debt ratio
-95.61%
Debt ratio change over time
-0.96%
Current Ratio
3.37%
Quick Ratio
0%
Cash Position Ratio
0.38%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CRVS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.91% | -3.05% | 11.55% | 6.27% |
| Return on assets | -11.76% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 276.3% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 59% |
| Total debt ratio | 10.41% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.96% | 6.09% | 6.03% | 1.53% |
| Dept financing | 3% | 50% | 43% | 14% |
| Current Ratio | 7.05% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.31% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 19% | 37% | 40% |
| Short-term ratios | CRVS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -17.91% | -25.62% | 17.94% | 7.14% |
| Return on assets | -15.22% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 178.09% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 60% |
| Total debt ratio | 16.86% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.91% | -23.44% | 9.66% | 0.6% |
| Dept financing | 4% | 25% | 45% | 8% |
| Current Ratio | 7.05% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 1.31% | 1.48% | 0.76% | 1.49% |
| Liquididy | 47% | 49% | 35% | 62% |